These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32705243)

  • 1. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
    Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
    Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
    Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
    Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
    Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
    Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
    Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
    Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.
    Liu X; Huang S; Guan Y; Zhang Q
    Oncol Rep; 2020 Aug; 44(2):599-610. PubMed ID: 32627026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
    Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMYD3 regulates the abnormal proliferation of non-small-cell lung cancer cells via the H3K4me3/ANO1 axis.
    Zhong D; Zhan Z; Zhang J; Liu Y; He Z
    J Biosci; 2022; 47():. PubMed ID: 36222132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
    Luo S; Shen M; Chen H; Li W; Chen C
    Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer.
    Zhu CL; Huang Q
    Dig Dis Sci; 2020 Feb; 65(2):489-499. PubMed ID: 31441002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
    Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
    Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
    Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.
    Xu YH; Tu JR; Zhao TT; Xie SG; Tang SB
    Int J Oncol; 2019 Jan; 54(1):295-305. PubMed ID: 30431074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells.
    Zhou X; Sun T; Meng Y; Luo J; Chen J; Xia B; Zhang Z; Cheng Z; Wang X
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.